Direkt zum Inhalt
Merck
  • Development of a nanoparticle that releases nucleic acids in response to a mitochondrial environment.

Development of a nanoparticle that releases nucleic acids in response to a mitochondrial environment.

Mitochondrion (2020-02-26)
Yuma Yamada, Yutaka Fukuda, Daisuke Sasaki, Minako Maruyama, Hideyoshi Harashima
ZUSAMMENFASSUNG

The delivery of nucleic acids targeting mutant mtDNA represent a potential strategy for addressing a variety of mitochondria-related diseases. We previously developed a MITO-Porter, a nano carrier that is capable of delivering nanoparticles of nucleic acids to mitochondria of human cells. Here, we report on an investigation of a series of nanoparticles formed with various poly cationic peptides that can release nucleic acids in response to a mitochondrial environment. A significant relationship was found between the number of and the location of arginine and histidine residues in the peptide sequence and the release of nucleic acids in a mitochondrial environment.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Avanti
18:1 (Δ9-Cis) PE (DOPE), Avanti Research - A Croda Brand
Sigma-Aldrich
Cholesterylhemisuccinat
Avanti
18:1 (Δ9-Cis) PE (DOPE), Avanti Research - A Croda Brand
Sigma-Aldrich
L-α-Phosphatidylethanolamin, Dioleoyl, ≥99% (GC), ≥98% (TLC), lyophilized powder
Sigma-Aldrich
Tetramethylrhodamin-methylester-perchlorat, ≥95%